Home
Conditions
Gaucher Disease

Clinical trial condition

Gaucher Disease

Explore clinical trials studying Gaucher Disease. Study availability and eligibility vary by location and protocol.

131 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Gaucher Disease trial results

Not Yet Recruiting

A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion

NCT05669729

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3

NCT06523517

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Peking union medical college hospital Beijing, China

View Trial Details

Not Yet Recruiting

Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency

NCT06258577

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: China Medical University Hospita Taichung, Taiwan

View Trial Details

Completed

Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations

NCT00302146

Conditions: Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +20 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

NCT03485677

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations: Investigational Site Number : 0320001 Buenos Aires, Argentina

Investigational Site Number : 1240002 Calgary, Alberta, Canada

Investigational Site Number : 1240003 Vancouver, British Columbia, Canada

Investigational Site Number : 1240001 Toronto, Ontario, Canada

View all 21 locations

View Trial Details

Completed

A Gene Therapy Study in Patients With Gaucher Disease Type 1

NCT05324943

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: Kaiser Permanente Los Angeles, California, United States

Lysosomal Rare Disorders Research and Treatment Center Fairfax, Virginia, United States

Hospital de Clinicas de Porto Alegre (HCPA) Porto Alegre, Brazil

SphinCS Höchheim, Germany

View Trial Details

Completed

Survey Study for Velaglucerase Alfa (VPRIV) in Japan

NCT03625882

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Konan Kōnan, Aichi-ken, Japan

Nagoya Nagoya, Aichi-ken, Japan

Kitakyushu Kitakyushu, Fukuoka, Japan

Kurume Kurume, Fukuoka, Japan

View all 35 locations

View Trial Details

Completed

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

NCT05641103

Conditions: ASMD, Acid Sphingomyelinase Deficiency, Brain Diseases, +25 more
Locations: Hospital General Universitario de Alicante Alicante, Spain

Hospital de Poniente El Ejido, Almería, Spain

Hospital Universitario de Badajoz Badajoz, Spain

Hospital Vall d'Hebron Barcelona, Spain

View all 14 locations

View Trial Details

Completed

Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

NCT02583672

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

New York University New York, United States

View Trial Details

Completed

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

NCT04845958

Conditions: Acid Sphingomyelinase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +25 more
Locations: Investigational Site Number 2500036 Amiens, France

Investigational Site Number 2500014 Angers, France

Investigational Site Number 2500034 Argenteuil, France

Investigational Site Number 2500039 Bayonne, France

View all 40 locations

View Trial Details

Gaucher Disease

Gaucher Disease trial results

Related conditions